Ask any seasoned investor what makes a technology business truly valuable, and you’ll often hear one word: recurring. Unlike one-off sales that constantly require new customers, recurring revenue compounds over time, delivering predictability and operating leverage. It’s why subscription businesses, SaaS platforms, and ad-driven ecosystems often trade at premium valuations

FDA Fast Track Momentum: On August 26, 2025, Allarity Therapeutics saw its stock skyrocket—up nearly 100%, with some sources even reporting over 110%—after the U.S. FDA granted Fast Track designation to stenoparib, its investigational treatment for advanced ovarian cancer Investing.com+12TipRanks+12Allarity Therapeutics+12.

OSR Holdings (NASDAQ: OSRH), a healthcare-focused blank-check company, has exploded in the market today. The stock surged over 100% intraday, driven by a massive 106.8% jump on extraordinary volume of 188 million shares.

MIDDLETOWN, Ohio – August 21, 2025 — EpicQuest Education Group International Limited (NASDAQ: EEIQ), a provider of comprehensive education solutions for domestic and international students, announced robust financial results for the first half of fiscal 2025, demonstrating momentum fueled by global expansion initiatives.

Aptorum Group Limited (NASDAQ: APM), a clinical-stage biopharmaceutical firm with a focus on oncology, infectious diseases, and diagnostics initiatives, is undergoing a transformative pivot. Today’s headlines center on its definitive merger agreement with DiamiR Biosciences—coupled with a recent regulatory milestone—that positions the combined company to lead in neurodiagnostics and Alzheimer’s testing.